BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Central Standard Time
X-LIC-LOCATION:America/Chicago
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:CST
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:CDT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2026 Annual Meeting by the ΊΓΙ«ΟΘΙϊ\n\nTi
 tle: Industry Therapeutic Update From Alexion\, AstraZeneca Rare Disease:
  From Pathophysiology to Practice-Expert Perspective[s] on C5 Inhibition 
 in Anti-AChR Antibody-Positive gMG and Practical Approaches\n\nAccess URL
 : /msa/Public/Events/GetEventURL/23122\n\nLearn More A
 bout This Event: /msa/Public/Events/Details/23122
DTEND;TZID=Central Standard Time:20260421T124500
DTSTAMP:20260131T122906Z
DTSTART;TZID=Central Standard Time:20260421T114500
LOCATION:/msa/Public/Events/GetEventURL/23122
SEQUENCE:0
SUMMARY:AAN: Industry Therapeutic Update From Alexion\, AstraZeneca Rare D
 isease: From Pathophysiology to Practice-Expert Perspective[s] on C5 Inhi
 bition in Anti-AChR Antibody-Positive gMG and Practical Approaches
UID:09bd84b6-e39f-4413-8ccd-bceced16ea71
END:VEVENT
END:VCALENDAR